Pancreatic Cancer Research

ResearcherHumboldt-Universität zu BerlinNo recent work listed

Nathalie Rosumeck

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3697-9647; OpenAlex author ID A5005195842. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

  1. Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma-Who Will Benefit from a Secondary Resection? Co-author DOI 10.3390/medicina57010077↗
  2. Neoadjuvant Chemotherapy Enhances Local Postoperative Histopathological Tumour Stage in Borderline Resectable Pancreatic Cancer - A Matched-Pair Analysis. First author DOI 10.21873/anticanres.13781↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marcus Bahra · 2 shared papers, 2019–2021 · strength 0.25
  2. Thomas Malinka · 2 shared papers, 2019–2021 · strength 0.25
  3. Fritz Klein · 2 shared papers, 2019–2021 · strength 0.25
  4. Lea Timmermann · 2 shared papers, 2019–2021 · strength 0.25
  5. Uwe Pelzer · 2 shared papers, 2019–2021 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.